Professor Bruce Johnson
- 丹娜—法伯癌症研究所医学教授; 哈佛医学院 研究所医师
Bruce E. Johnson, MD, is the Co-Director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute and Co-leader of the Dana-Farber/Harvard Cancer Center Lung Cancer Program. He is a Professor of Medicine at Harvard Medical School, an Institute physician at the Dana-Farber Cancer Institute, and a Senior Advisor to the President and CEO of the Dana-Farber Cancer Institute. Dr Johnson served on the American Society for Clinical Oncology (ASCO) Board of Directors from 2008 to 2011, received their Cancer Foundation’s Translational Research Professorship in 2008, and was selected as an ASCO fellow in 2012. He was elected president of ASCO for the 2017-2018 term.